research use only
Cat.No.S2377
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other FAAH Inhibitors | URB597 PF-3845 JNJ-42165279 PF-04457845 FAAH-IN-2 JZL195 URB937 JNJ-1661010 BIA 10-2474 LY-2183240 |
|
In vitro |
DMSO
: 56 mg/mL
(197.0 mM)
Ethanol : 16 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 284.26 | Formula | C16H12O5 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 491-80-5 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | 4-Methylgenistein | Smiles | COC1=CC=C(C=C1)C2=COC3=CC(=CC(=C3C2=O)O)O | ||
| Targets/IC50/Ki |
FAAH (rat)
1.4 μM
FAAH (mouse)
1.8 μM
FAAH (human)
2.4 μM
EGFR
91.5 μM
|
|---|---|
| In vitro |
Biochanin A has been reported to inhibit protein tyrosine kinase (PTK) of epidermal growth factor receptor with IC50 values of 91.5 μM This compound inhibits the hydrolysis of 0.5 μM anandamide by mouse, rat and human fatty acid amide hydrolase (FAAH) with IC50 values of 1.8, 1.4 and 2.4 μM respectively. It inhibits both serum and EGF-stimulated growth of LNCaP and DU-145 cells (IC50 values from 8.0 to 27 micrograms/ml for serum and 4.3 to 15 micrograms/ml for EGF), but has no significant effect of the EGF receptor tyrosine autophosphorylation.
|
| In vivo |
LD50: Mice 63mg/kg (i.p.)
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.